Becoming Local Takes More Than Opening an Office

Over the past several years, I have spent a significant amount of my time in the United States.

When PQE Group began expanding internationally, like many companies, we had to make decisions about where to open offices, where to hire and where our services could support existing demand. Those decisions matter, although experience has taught me that they are only the beginning of international growth.

A company can establish a legal entity relatively quickly. It can lease an office, recruit a team and begin introducing itself to prospective clients. The more difficult work comes afterward, when the company has to become genuinely familiar to the market around it.

This is something I think about frequently as PQE Group continues developing its presence across the United States.

Presence creates information

You can research a market extensively before entering it. You can study investment numbers, analyze competitors, identify major companies and understand where the largest industry clusters are located.

Being present gives you another layer of information.

When I spend time with our clients and teams in the United States, I hear which problems appear repeatedly across different organizations. I see where companies are investing, which skills are difficult to find and how quickly priorities can change when a new technology or regulatory expectation enters the conversation.

Those observations influence business decisions because they reveal patterns that are difficult to see from headquarters.

Recent investments in U.S. pharmaceutical manufacturing make this especially relevant today. Bristol Myers Squibb announced a $2.3 billion manufacturing campus in Houston in August, while other pharmaceutical companies have continued announcing significant investments in manufacturing and research across the country.

Facilities of this scale eventually create demand far beyond construction. They require engineers, quality professionals, validation expertise, digital systems, regulatory knowledge and experienced people capable of operating complex manufacturing environments.

For a company serving life sciences, understanding where these capabilities are developing is an important part of understanding the market.

Clients need to know who is actually there

International companies sometimes underestimate how local professional relationships remain, particularly in industries built around technical expertise.

Clients want to understand who will be working with them. They want to know whether the people around the table understand their environment and whether those people will remain accessible once a contract has been signed.

That relationship develops over time.

One of the strongest examples for PQE Group came during our recent U.S. Roadshow in Raleigh. The event worked particularly well because there was already a connected life sciences community around it. Clients attended and brought colleagues, people in the room knew one another and the conversation moved naturally between the panel and the audience.

The value was not simply attendance. The room had a level of familiarity that allowed people to participate.

That experience reinforced something we had already seen in other markets. An established community can become one of the strongest assets a life sciences region has.

Local leadership matters

International organizations also need people who understand how work happens in the market itself.

Leadership expectations, communication styles, decision making and client relationships can vary significantly between countries. A company can maintain the same values and technical standards internationally while still giving local leaders the space to understand how those standards should be applied in their environment.

I have always believed strongly in this.

The United States is a particularly important example because the market is large enough to contain several very different life sciences ecosystems. Boston, Raleigh, Chicago, the West Coast and other major regions each have different concentrations of expertise, companies and relationships.

Treating them as one uniform market misses much of what makes them useful.

Offices should become part of the community

This is also how I think about physical offices.

An office should eventually become more than an address on a website. It should give people a place to work together, meet clients, invite colleagues into a conversation and participate in the professional community surrounding it.

We are currently preparing another gathering at our Libertyville office in the Chicago area, and I am interested in developing that location in this way.

The Chicago region already has an established pharmaceutical and life sciences community. Our responsibility as we grow there is to become increasingly connected to it through the people we hire, the clients we support and the relationships we build over time.

International growth requires patience

There is a temptation to measure international expansion through visible milestones such as offices opened, employees hired and revenue generated.

Those measurements are useful, although they do not capture the full process.

Becoming established in a market requires repetition. Clients need to encounter the company more than once. Teams need time to develop reputations of their own. Leaders need to understand where the organization fits into the wider industry community.

I have learned to appreciate that process more as PQE Group has grown.

Entering a market can happen relatively quickly. Becoming part of it happens through years of work, relationships and presence.

That is the part that eventually makes international growth sustainable.

Read Next

The Reverse Centaur’s Guide to Life After AI by Cory Doctorow

The Reverse Centaur’s Guide to Life After AI by Cory Doctorow

This summer, I have been spending a great deal of time on the road across the United States. Travel always gives me a little more room to read, think, and step outside the pace of daily business. One of the books I picked up along the way was Cory Doctorow’s The...

Where Will the Next Generation of Senior Pharma Consultants Come From?

Where Will the Next Generation of Senior Pharma Consultants Come From?

I find myself returning to this question often. I do not yet have a complete answer. Much of what shaped my professional judgment early in my career came from work that was repetitive, detailed, and largely invisible from the outside. Routine validation activities....

AI in Life Sciences: The Wrong Question Is Costing You the Right Answer

AI in Life Sciences: The Wrong Question Is Costing You the Right Answer

Will AI replace regulators, quality professionals, and clinical judgment? This question is sparking heated and fearful debate regarding the integration of AI into the Life Sciences industry. But, contrary to popular belief, the issues do not lie in the incorporation...